CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. The company leverages human multiomics data to better navigate complex disease biology to identify novel and differentiated therapeutics.
CardiaTec is building the first and largest proprietary human heart tissue multiomics dataset. The company has a large and growing network of over 65 hospitals across the US and the UK, screening patients on a 24/7 basis to support the bespoke collection of human cardiac tissues.
The company spun out of the Han Lab at the University of Cambridge and has brought together industry experts from leading organisations including Bristol Myers Squibb, Cleveland Clinic and Recursion Pharmaceuticals.
Company Details
- Employees
- 15
- Founded
- -
- Address
- Cambridge , Gb
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cardiatec.ai/
- Keywords
- into unified.
- HQ
- Cambridge
Cardiatec Bio Questions
Cardiatec Bio's website is https://www.cardiatec.ai/
Cardiatec Bio's LinkedIn profile is https://uk.linkedin.com/company/cardiatec
Cardiatec Bio has
15 employees.
View email and phone details for 15
employees at Cardiatec Bio.
Cardiatec Bio's industry is
Biotechnology Research
Cardiatec Bio's top competitors are
Chai Discovery,
Candid Therapeutics,
Safi Biotherapeutics Inc,
Radiant Biotherapeutics,
Superluminal Medicines Inc.,
Vironexis Biotherapeutics,
Nanosyrinx,
Montage Ventures,
Pantera,
Phoremost Ltd.
Cardiatec Bio's categories are Biotechnology Research
Cardiatec Bio's founding year is 2021
